Telitacicept
RemeGen
['telitacicept']
don't miss joining our co-editor-in-chief's in session op0142 at #eular2023 taking place in south hall, session room 2 at 10:30am. learn about efficacy and safety of telitacicept, a novel blys/april dual inhibitor, in patients with primary sj gren s syndrome
The official #OpenAccess journal of the @LupusOrg published by @BMJ_company creating a barrier-free forum for #lupus #research